ASIX:NYE-AdvanSix Inc (USD)

COMMON STOCK | Chemicals |

Last Closing

USD 28.52

Change

+0.16 (+0.56)%

Market Cap

USD 0.76B

Volume

0.12M

Analyst Target

USD 20.00
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

AdvanSix Inc. engages in the manufacture and sale of polymer resins in the United States and internationally. It offers Nylon 6, a polymer resin, which is a synthetic material used to produce fibers, filaments, engineered plastics, and films. The company also provides caprolactam to manufacture polymer resins; ammonium sulfate fertilizers to distributors, farm cooperatives, and retailers; and acetone that are used in the production of adhesives, paints, coatings, solvents, herbicides, and engineered plastic resins, as well as other intermediate chemicals, including phenol, monoisopropylamine, dipropylamine, monoallylamine, alpha-methylstyrene, cyclohexanone, methyl ethyl ketoxime, acetaldehyde oxime, 2-pentanone oxime, cyclohexanol, sulfuric acid, ammonia, and carbon dioxide. It offers its products under the Aegis, Capran, Sulf-N, Nadone, Naxol, and EZ-Blox brands. The company sells its products directly, as well as through distributors. AdvanSix Inc. was incorporated in 2016 and is headquartered in Parsippany, New Jersey. Address: 300 Kimball Drive, Parsippany, NJ, United States, 07054

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-30 )

Largest Industry Peers for Chemicals

Symbol Name Price(Change) Market Cap
HUN Huntsman Corporation

+0.12 (+0.54%)

USD 3.97B
BAK Braskem SA Class A

-0.08 (-1.29%)

USD 2.46B
TROX Tronox Holdings PLC

+0.18 (+1.49%)

USD 2.12B
VHI Valhi Inc

-0.12 (-0.34%)

USD 1.00B
WLKP Westlake Chemical Partners LP

+0.12 (+0.53%)

USD 0.80B
RYAM Rayonier Advanced Materials

+0.12 (+1.52%)

USD 0.52B
CE Celanese Corporation

+0.14 (+0.11%)

N/A
LXU Lsb Industries Inc

-0.24 (-2.85%)

N/A
DOW Dow Inc

-0.14 (-0.28%)

N/A
REX REX American Resources Corpora..

+0.11 (+0.25%)

N/A

ETFs Containing ASIX

N/A

Market Performance

  Market Performance vs. Industry/Classification (Chemicals) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -4.81% 73% C 25% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -4.81% 73% C 34% F
Trailing 12 Months  
Capital Gain 4.74% 73% C 30% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 4.74% 82% B 38% F
Trailing 5 Years  
Capital Gain 25.20% 73% C 65% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 25.20% 73% C 66% D+
Average Annual (5 Year Horizon)  
Capital Gain 34.33% 73% C 90% A-
Dividend Return 35.04% 64% D 89% A-
Total Return 0.71% 13% F 17% F
Risk Return Profile  
Volatility (Standard Deviation) 75.95% 55% F 11% F
Risk Adjusted Return 46.14% 64% D 63% D
Market Capitalization 0.76B 29% F 54% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low debt

The company is less leveraged than its peers ,, and is among the top quartile, which makes it more flexible. However, do check the news and look at its sector. Sometimes this is low because the company is not growing and has no growth potential.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Poor return on assets

The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector

Low Dividend Growth

This stock has shown below median dividend growth in the previous 5 years compared to its sector.